Uses supported by clinical data
The European Medicines Agency (EMA ) accepts its traditional use for relief of symptoms of asthenia such as fatigue and weakness.
Most clinical studies relates to their effectiveness on physical and cognitive function at different levels :
– Improves mental and physical performance in situations of fatigue, as well as the ability to work : decreases the severity of fatigue after practice intense physical exercise, reduces recovery time and improves circulatory adaptation to exercise (pulse pressure blood).
– Effect on depression and anxiety: produces an improvement in symptoms of depression according to the Hamilton scale for depression (HAMD) and reduces anxiety levels in the Hamilton Anxiety Scale (HARS) .
– Increases visual perception, short-term memory and attention. In clinical trials it has been observed that produces improvement, dose-dependently, in all the parameters studied: exhaustion, reduced motivation, somnolence, decreased libido, sleep disorders and cognitive impairment.
It not established the safety of use in pregnancy, lactation and children .